Ingredia files structure function claims for blood sugar ingredient

1-Apr-2022

With 88 million of prediabetics estimated by the CDC, of which 80% will turn diabetic within 5 to 10 years if nothing is done, the prevention of diabetes is a strong concern in the US

Ingredia has launched Pep2Dia, an inhibitor of the alpha-glucosidase enzyme designed to help with the reduction of post-meal glycemia peak, and consequently with maintaining healthy blood sugar levels.

Following a NDI status obtained in February, Ingredia has notified to FDA two structure function claims for the ingredient:

  • Helps to maintain healthy blood sugar levels after meals
  • Helps to support healthy blood sugar levels

With 88 million of prediabetics estimated by the CDC, of which 80% will turn diabetic within 5 to 10 years if nothing is done, the prevention of diabetes is a strong concern in the US.

Sign up for your free email newsletter

Reaching this stage of worrying blood sugar levels can happen quite easily after 40 years old, Ingredia says, especially with a family history of diabetes, obesity, a lack of physical activity and/or an unbalanced diet challenging your pancreas function.

Featured Companies